Open Access Research Article

The Neutropenic Patient with Fever

Adrian Hunis MD*

Emeritus Member of ASCO, Emeritus Member of ESMO, School of Medicine. Universidad de Buenos Aires (UBA)

Corresponding Author

Received Date: November 18, 2021;  Published Date: December 06, 2021

Abstract

Advances in chemotherapy treatments have had a significant impact on the survival of cancer patients, but they can alter the normal flora and the indemnity of natural barriers. This favors the entry of germs that are normally colonizers, making them infectious for the susceptible host. In turn, these treatments, acting on rapidly replicating cells, such as blood cells and those of the digestive tract, produce a decrease in polymorphonuclear cells with which cancer patients are more susceptible to infections.

Citation
Signup for Newsletter
Scroll to Top